Abstract
Background: Obesity, a chronic low-grade inflammatory disease characterized by multiple metabolic dysfunctions, poses a considerable worldwide health risk to adults and children. Clove has also shown that it possesses anti-inflammatory, anti-fungal, antibacterial, antioxidant, antiglycation, and anti-aging properties. Aim: The current study aimed to investigate the antiobesity effect of clove-loaded chitosan nanoparticles in obese rats. objective: The current study investigated the antiobesity effect of clove-loaded chitosan nanoparticles in obese rats. Method: Obesity is induced in rats by the administration of a High-Fat Diet (HFD) for 4 weeks. 24 rats were divided into 4 groups; Control group, in which rats were fed normal; HDF group, in which rats were HFD along with distilled water; HFD + empty nanoparticles (ENPs), in which rats were HFD along with ENPs (45 mg/kg); and HFD + clove nanoparticles (CNPs), in which rats were HFD along with CNPs (45 mg/kg) for four weeks. Results: Administration of ENPs and CNPs led to a notable reduction in glucose, aminotransferases, alkaline phosphatase, cholesterol, triglycerides, low-density lipoproteins, malondialdehyde, nitric oxide, caspase-3, PCNA, leptin, and DNA fragmentation. Additionally, it promoted an increase in total proteins, albumin, high-density lipoprotein, glutathione, catalase, and adiponectin. Also, the histopathological investigation of the liver and kidney showed the protective effect of ENPs and CNPs on the tissues of obese rats. Conclusion: The present investigation elucidated the preventive effects of chitosan nanoparticles loaded with clove on dyslipidemia in obese rats. Clove nanoparticles exhibited hypolipidemia, antioxidant, hypoglycemia, and hepatoprotective activities.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call